solace biotch product's start with letter "g"
TRANSCRIPT
Solace Biotech Product s
Name of BraNds start With alphaBet “G”
Glymon –G1Glymon – G2
G
Glymon – G1 BilayeredTabletsEach bilayered tablet contains:Glimepiride 1 mgMetformin (sustained release) 500 mgAnti-diabetic
DESCRIPTION:
GlimepirideThe primary mechanism of action of glimepiride in lowering blood glucose appears to be dependent onstimulating the release of insulin from functioning pancreatic beta cells. In addition, extra pancreatic effectsmay also play a role in the activity of sulphonylureas such as glimepiride.
MetforminMetformin is an oral antihyperglyacemic drug used in the management of type 2 diabetes. It improves glucose tolerance in patients with type 2 diabetes (NIDDM).Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, improvesinsulin sensitivity by increasing peripheral glucose uptake and utilization.
Glymon – G2 BilayeredTabletsEach bilayered tablet contains:Glimepiride 2 mgMetformin (sustained release) 500 mgAnti-diabetic
DESCRIPTION:
GlimepirideThe primary mechanism of action of glimepiride in lowering blood glucose appears to be dependent onstimulating the release of insulin from functioning pancreatic beta cells. In addition, extra pancreatic effectsmay also play a role in the activity of sulphonylureas such as glimepiride.
MetforminMetformin is an oral antihyperglyacemic drug used in the management of type 2 diabetes. It improves glucose tolerance in patients with type 2 diabetes (NIDDM).Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, improvesinsulin sensitivity by increasing peripheral glucose uptake and utilization.
DESCRIPTION:
GlimepirideThe primary mechanism of action of glimepiride in lowering blood glucose appears to be dependent onstimulating the release of insulin from functioning pancreatic beta cells. In addition, extra pancreatic effectsmay also play a role in the activity of sulphonylureas such as glimepiride.
MetforminMetformin is an oral antihyperglyacemic drug used in the management of type 2 diabetes. It improves glucose tolerance in patients with type 2 diabetes (NIDDM).Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, improvesinsulin sensitivity by increasing peripheral glucose uptake and utilization.